Fenghe Qiu

423 total citations
22 papers, 280 citations indexed

About

Fenghe Qiu is a scholar working on Spectroscopy, Materials Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Fenghe Qiu has authored 22 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Spectroscopy, 5 papers in Materials Chemistry and 4 papers in Computational Theory and Mathematics. Recurrent topics in Fenghe Qiu's work include Analytical Chemistry and Chromatography (6 papers), Computational Drug Discovery Methods (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Fenghe Qiu is often cited by papers focused on Analytical Chemistry and Chromatography (6 papers), Computational Drug Discovery Methods (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). Fenghe Qiu collaborates with scholars based in United States, Germany and United Kingdom. Fenghe Qiu's co-authors include Daniel L. Norwood, James A. McCloskey, P. F. Crain, Carl A. Busacca, Jef Rozenski, Magnus Eriksson, Regina C. So, Hanlin Li, R. David Simpson and Scot Campbell and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and The Journal of Organic Chemistry.

In The Last Decade

Fenghe Qiu

21 papers receiving 261 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fenghe Qiu United States 8 96 81 76 71 42 22 280
L. K. Ravindranath India 10 65 0.7× 65 0.8× 114 1.5× 168 2.4× 17 0.4× 46 365
Van D. Reif United States 9 123 1.3× 44 0.5× 65 0.9× 66 0.9× 29 0.7× 13 291
Patrick J. Jansen United States 8 98 1.0× 74 0.9× 91 1.2× 40 0.6× 37 0.9× 18 262
Michael Chlenov United States 10 103 1.1× 85 1.0× 47 0.6× 64 0.9× 12 0.3× 21 263
A. V. S. S. Prasad India 13 146 1.5× 45 0.6× 130 1.7× 138 1.9× 7 0.2× 29 405
Timothy Nowak United States 9 149 1.6× 88 1.1× 85 1.1× 87 1.2× 14 0.3× 15 308
Rolf Schulte Oestrich United Kingdom 8 86 0.9× 25 0.3× 41 0.5× 101 1.4× 24 0.6× 10 256
J. Satyanarayana India 12 32 0.3× 86 1.1× 40 0.5× 167 2.4× 31 0.7× 25 340
Tapon Roy United States 5 40 0.4× 91 1.1× 41 0.5× 40 0.6× 191 4.5× 10 350
Andrew M. Lipczynski United Kingdom 8 198 2.1× 35 0.4× 99 1.3× 66 0.9× 9 0.2× 12 344

Countries citing papers authored by Fenghe Qiu

Since Specialization
Citations

This map shows the geographic impact of Fenghe Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fenghe Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fenghe Qiu more than expected).

Fields of papers citing papers by Fenghe Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fenghe Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fenghe Qiu. The network helps show where Fenghe Qiu may publish in the future.

Co-authorship network of co-authors of Fenghe Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Fenghe Qiu. A scholar is included among the top collaborators of Fenghe Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fenghe Qiu. Fenghe Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chi‐wan, Elke Debie, Mingkun Fu, et al.. (2021). Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies. The AAPS Journal. 23(6). 107–107. 16 indexed citations
2.
Smith, Susan M., et al.. (2021). Lean Stability Approaches in Pharmaceutical Product Development, Registration, and Post-marketing CMC Change Management; Industry Survey Insights. Journal of Pharmaceutical Innovation. 17(3). 856–866. 2 indexed citations
3.
Waterman, Kenneth C., et al.. (2021). Stability screening of pharmaceutical cocrystals. Pharmaceutical Development and Technology. 26(10). 1130–1135. 4 indexed citations
4.
Williams, Helen Elizabeth, Elke Debie, Mingkun Fu, et al.. (2020). Utilization of risk-based predictive stability within regulatory submissions; industry’s experience. SHILAP Revista de lepidopterología. 6(1). 15 indexed citations
5.
Dill, Allison L., et al.. (2020). Lean Stability Case Studies—Leveraging Science- and Risk-Based Approaches to Enable Meaningful Phase Specific Pharmaceutical Stability Strategies. Journal of Pharmaceutical Innovation. 16(3). 566–574. 3 indexed citations
6.
Qiu, Fenghe, et al.. (2015). Monitoring the chemical and physical stability for tromethamine excipient in a lipid based formulation by HPLC coupled with ELSD. Journal of Pharmaceutical and Biomedical Analysis. 115. 245–253. 7 indexed citations
9.
Qiu, Fenghe, et al.. (2013). Control of Genotoxic Impurities in Pharmaceutical Products. 656–669.
10.
Qiu, Fenghe, et al.. (2012). Application of iChemExplorer in pharmaceutical pH stress testing. Journal of Pharmaceutical and Biomedical Analysis. 76. 219–224. 2 indexed citations
11.
Latli, Bachir, Matt Hrapchak, Yibo Xu, et al.. (2011). Synthesis of a highly potent leukocyte function‐associated antigen‐1 antagonist and its metabolite labeled with stable isotopes and carbon‐14, part 2. Journal of Labelled Compounds and Radiopharmaceuticals. 54(13). 799–808. 1 indexed citations
12.
Qiu, Fenghe, et al.. (2009). Identification of a process impurity formed during synthesis of a nevirapine analogue HIV NNRT inhibitor using LC/MS and forced degradation studies. Journal of Pharmaceutical and Biomedical Analysis. 49(3). 733–738. 6 indexed citations
13.
Papov, Vladimir V., et al.. (2008). Genotoxic Impurities: A Quantitative Approach. Journal of Liquid Chromatography & Related Technologies. 31(15). 2318–2330. 19 indexed citations
14.
Qiu, Fenghe, et al.. (2008). Identification of Drug Meglumine Interaction Products Using LC/MS and Forced Degradation Studies. Journal of Liquid Chromatography & Related Technologies. 31(15). 2331–2336. 1 indexed citations
15.
Qiu, Fenghe & Daniel L. Norwood. (2007). Identification of Pharmaceutical Impurities. Journal of Liquid Chromatography & Related Technologies. 30(5-7). 877–935. 95 indexed citations
16.
Busacca, Carl A., Scot Campbell, Anjan K. Saha, et al.. (2005). Structure elucidation and total synthesis of a unique group of trace impurities in Tipranavir® drug product. Magnetic Resonance in Chemistry. 43(12). 1032–1039. 5 indexed citations
17.
Gallou, Fabrice, et al.. (2004). A Practical Synthesis of 2-Aryl-Indole-6-carboxylic Acids. Synlett. 883–885. 7 indexed citations
18.
Busacca, Carl A., Scot Campbell, Yong Qiang Dong, et al.. (2004). Electronic Control of Chiral Quaternary Center Creation in the Intramolecular Asymmetric Heck Reaction. The Journal of Organic Chemistry. 69(16). 5187–5195. 38 indexed citations
19.
Qiu, Fenghe. (1999). Selective detection of ribose-methylated nucleotides in RNA by a mass spectrometry-based method. Nucleic Acids Research. 27(18). 20e–20. 17 indexed citations
20.
McCloskey, James A., et al.. (1999). New Techniques for the Rapid Characterization of Oligonucleotides by Mass Spectrometry. Nucleosides and Nucleotides. 18(6-7). 1549–1553. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026